Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pamidronic acid

Drug Profile

Pamidronic acid

Alternative Names: AHPrBP; Amino hydroxypropylidene diphosphonic acid; Aminomux; APD; Aredia; CGP 23339A; CGP 23339AE; Disodium aminohydroxypropylidenediphosphonate; Disodium pamidronate; IG 7913; Pamidronate sodium; Panorin

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Gador; Henkel
  • Developer Andromaco; Drogueria Marco-Med; Gador Paraguay; Hanlim Pharmaceutical; Leti; MAC Laboratories; Nippon Kayaku; Novartis; Raices; Seignior Pharma; Sued Farmaceutica
  • Class Antihypercalcaemics; Bisphosphonates; Calcium regulators; Osteoporosis therapies; Small molecules
  • Mechanism of Action Bone resorption factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Cancer metastases; Malignant hypercalcaemia; Osteitis deformans; Osteogenesis imperfecta; Osteoporosis; Postmenopausal osteoporosis
  • No development reported Bone cancer; Cancer pain

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 24 May 2005 Clinical data from a media release have been added to the adverse events section
  • 09 Mar 2005 Data from a media release have been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top